Henrik Svennberg
Papers
2
Total Citations
30
H-Index
2
About
Henrik Svennberg is a distinguished bioanalytical chemist whose work has significantly advanced the field of high-throughput bioanalysis, particularly in the quantification of pharmaceutical compounds in biological matrices. His research focuses on the development and optimization of automated solid-phase extraction (SPE) techniques coupled with liquid chromatography–tandem mass spectrometry (LC–MS/MS), enabling rapid, sensitive, and reliable drug analysis. Svennberg’s major contributions include pioneering factorial design approaches for automated 96-well SPE, as demonstrated in his highly cited 2003 study on tesaglitazar determination, which streamlined method development and reduced sample preparation time. His 2007 work on ximelagatran and its metabolites further showcased his expertise in multi-analyte quantification, providing robust methodologies for pharmacokinetic studies. With over 30 citations from these seminal papers, Svennberg’s impact is evident in the widespread adoption of his automated SPE strategies in pharmaceutical research and clinical laboratories. His innovative approaches have not only enhanced analytical efficiency but also set new standards for precision in drug metabolism and bioequivalence studies, making him a key figure in modern bioanalytical science.
Research Focus
Key Achievements
Top Papers
- 1
- 2